• 7785 Citations
  • 37 h-Index
1987 …2024
If you made any changes in Pure these will be visible here soon.

Research Outputs 1987 2019

Doctor-patient communication: a study of Australian ethnic urological cancer patients

Cerimagic, S., Ahmadi, N., Gurney, H. & Patel, M. I., 1 Jun 2015, In : International Journal of Human Rights in Healthcare. 8, 2, p. 82-91 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Urologic Neoplasms
cancer
Communication
communication
illness

Dose calculation of anticancer drugs

Gao, B., Klumpen, H. J. & Gurney, H., Oct 2008, In : Expert Opinion on Drug Metabolism and Toxicology. 4, 10, p. 1307-1319 13 p.

Research output: Contribution to journalReview articleResearchpeer-review

Pharmaceutical Preparations
Drug Monitoring
Body Surface Area
Poisons
Therapeutic Uses

Dose calculation of anticancer drugs: A review of the current practice and introduction of an alternative

Gurney, H., 1996, In : Journal of Clinical Oncology. 14, 9, p. 2590-2611 22 p.

Research output: Contribution to journalReview articleResearchpeer-review

Body Surface Area
Drug Monitoring
Pharmaceutical Preparations
Pharmacokinetics
docetaxel

Dose considerations for anti-cancer drugs in metastatic prostate cancer

Crumbaker, M. & Gurney, H., 1 Aug 2017, In : Prostate. 77, 11, p. 1199-1204 6 p.

Research output: Contribution to journalReview articleResearchpeer-review

docetaxel
Prostatic Neoplasms
Pharmaceutical Preparations
Neoplasms
Quality of Life

Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study

Fox, P., Balleine, R. L., Lee, C., Gao, B., Balakrishnar, B., Menzies, A. M., Yeap, S. H., Ali, S. S., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wong, M., Wilcken, N. & Gurney, H., 1 Jul 2016, In : Clinical Cancer Research. 22, 13, p. 3164-3171 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Drug Monitoring
Tamoxifen
Hot Flashes
Cytochrome P-450 CYP2D6
Genotype

Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring

Sabanathan, D., Zhang, A., Fox, P., Coulter, S., Gebski, V., Balakrishnar, B., Chan, M., Liddle, C. & Gurney, H., Aug 2017, In : Cancer Chemotherapy and Pharmacology. 80, 2, p. 385–393 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Drug Monitoring
Renal Cell Carcinoma
Toxicity
Monitoring
Pharmaceutical Preparations

Dose intensity in cancer chemotherapy

Dodwell, D. J., Gurney, H. & Thatcher, N., 1990, In : British Journal of Cancer. 61, 6, p. 789-794 6 p.

Research output: Contribution to journalEditorialResearchpeer-review

Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective

Parente, P., Parnis, F. & Gurney, H., 2012, In : Asia-Pacific Journal of Clinical Oncology. 8, 1, p. 31-42 12 p.

Research output: Contribution to journalReview articleResearchpeer-review

docetaxel
Castration
Prostatic Neoplasms
Therapeutics
Drug Therapy

Environmental and genetic factors affecting transport of imatinib by OATP1A2

Eechoute, K., Franke, R. M., Loos, W. J., Scherkenbach, L. A., Boere, I., Verweij, J., Gurney, H., Kim, R. B., Tirona, R. G., Mathijssen, R. H. J. & Sparreboom, A., 2011, In : Clinical Pharmacology and Therapeutics. 89, 6, p. 816-820 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Drug Interactions
Duodenum
Biological Availability
Anions
Peptides

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice - part 1

Gurney, H., Dodwell, D., Thatcher, N. & Tattersall, M. H. N., Jan 1993, In : Annals of Oncology. 4, 1, p. 23-34 12 p.

Research output: Contribution to journalReview articleResearchpeer-review

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice -part 2

Gurney, H., Dodwell, D., Thatcher, N. & Tattersall, M. H. N., Feb 1993, In : Annals of Oncology. 4, 2, p. 103-115 13 p.

Research output: Contribution to journalReview articleResearchpeer-review

e-TC: development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer

Heiniger, L. E., Smith, A. B., Olver, I., Grimison, P., Klein, B., Wootten, A., Abbott, J-A. M., Price, M. A., McJannett, M., Tran, B., Stockler, M. R., Gurney, H. & Butow, P. N., Nov 2017, In : European Journal of Cancer Care. 26, 6, p. 1-10 10 p., e12698.

Research output: Contribution to journalArticleResearchpeer-review

Testicular Neoplasms
Survivors
Anxiety
Depression
Psychology

Evidence for therapeutic drug monitoring of targeted anticancer therapies

Gao, B., Yeap, S., Clements, A., Balakrishnar, B., Wong, M. & Gurney, H., 10 Nov 2012, In : Journal of Clinical Oncology. 30, 32, p. 4017-4025 9 p.

Research output: Contribution to journalReview articleResearchpeer-review

Drug Monitoring
Pharmacokinetics
Pharmaceutical Preparations
Immunosuppressive Agents
Intravenous Injections

Factors affecting epirubicin pharmacokinetics and toxicity: Evidence against using body-surface area for dose calculation

Gurney, H. P., Ackland, S., Gebski, V. & Farrell, G., Jul 1998, In : Journal of Clinical Oncology. 16, 7, p. 2299-2304 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Epirubicin
Body Surface Area
Pharmacokinetics
Neutropenia
Antipyrine

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Fox, P., Gao, B., Balakrishnar, B., Menzies, A. M., Yeap, S. H., Ali, S. S., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wilcken, N., Balleine, R. L. & Gurney, H., 20 May 2013, In : Journal of Clinical Oncology. 31, 15 supplement, p. 1-1 1 p., 543.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Fox, P., Gao, B., Balakrishnar, B., Menzies, A. M., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wilcken, N., Balleine, R. L. & Gurney, H., 1 Jul 2013, In : Asia-Pacific Journal of Clinical Oncology. 9, Supplement 2, p. 45-45 1 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma

Gurney, H., Crowther, D., Anderson, H., Murphy, D., Prendiville, J., Ranson, M., Mayor, P., Swindell, R., Buckley, C. H. & Tindall, V. R., 1990, In : Annals of Oncology. 1, 6, p. 427-433 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Carboplatin
Cyclophosphamide
Cisplatin
Carcinoma
Poisons

Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2

Zhou, F., Zheng, J., Zhu, L., Jodal, A., Cui, P. H., Wong, M., Gurney, H., Church, W. B. & Murray, M., 2013, In : AAPS Journal. 15, 4, p. 1099-1108 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Single Nucleotide Polymorphism
Biotinylation
Molecular Models
Membranes
HEK293 Cells

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

Gao, B., Lu, Y., Nieuweboer, A. J. M., Xu, H., Beesley, J., Boere, I., De Graan, A. J. M., De Bruijn, P., Gurney, H., Kennedy, C. J., Chiew, Y. E., Johnatty, S. E., Beale, P., Harrison, M., Luccarini, C., Conroy, D., Mathijssen, R. H. J., Harnett, P. R., Balleine, R. L., Chenevix-Trench, G. & 2 othersMacGregor, S. & De Fazio, A., 1 Dec 2018, In : Scientific Reports. 8, 1, p. 1-10 10 p., 1508.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Genome-Wide Association Study
Carboplatin
Paclitaxel
Single Nucleotide Polymorphism
Drug Therapy

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

Pettengell, R., Gurney, H., Radford, J. A., Deakin, D. P., James, R., Wilkinson, P. M., Kane, K., Bentley, J. & Crowther, D., 1992, In : Blood. 80, 6, p. 1430-1436 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Granulocyte Colony-Stimulating Factor
Neutropenia
Non-Hodgkin's Lymphoma
Randomized Controlled Trials
Chemotherapy

Haemopoietic cell kinetics in humans treated with rGM‐CSF

Lord, B. I., Gurney, H., Chang, J., Thatcher, N., Crowther, D. & Dexter, T. M., 1992, In : International Journal of Cancer. 50, 1, p. 26-31 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Bone Marrow
Granulocyte-Macrophage Colony-Stimulating Factor
Granulocytes
Small Cell Lung Carcinoma
Eosinophilia

Health-related quality-of-life analysis from KEYNOTE-045: a phase III study of pembrolizumab versus chemotherapy for previously treated advanced urothelial cancer

Vaughn, D. J., Bellmunt, J., Fradet, Y., Lee, J. L., Fong, L., Vogelzang, N. J., Climent, M. A., Petrylak, D. P., Choueiri, T. K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D. I., Culine, S., Sternberg, C. N., Mai, Y., Li, H., Perini, R. F., Bajorin, D. F. & de Wit, R., 1 Jun 2018, In : Journal of Clinical Oncology. 36, 16, p. 1579-1587 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Quality of Life
Drug Therapy
Neoplasms
Health Status
Research Personnel

Hemopoietic growth factors: Their clinical role

Gurney, H. & Crowther, D., 1990, In : Drugs of the Future. 15, 6, p. 581-595 15 p.

Research output: Contribution to journalReview articleResearchpeer-review

Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer

Wong, M., Evans, S., Rivory, L. P., Hoskins, J. M., Mann, G. J., Farlow, D., Clarke, C. L., Balleine, R. L. & Gurney, H., Jan 2005, In : Clinical Pharmacology and Therapeutics. 77, 1, p. 33-42 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Technetium Tc 99m Sestamibi
P-Glycoprotein
Single Nucleotide Polymorphism
Genotype
Liver

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation

Nath, C. E., Trotman, J., Tiley, C., Presgrave, P., Joshua, D., Kerridge, I., Kwan, Y. L., Gurney, H., McLachlan, A. J., Earl, J. W., Nivison-Smith, I., Zeng, L. & Shaw, P. J., Jul 2016, In : British Journal of Clinical Pharmacology. 82, 1, p. 149-159 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Melphalan
Autologous Transplantation
Area Under Curve
Survival
Stem Cell Transplantation

Hodgkin's disease presenting with central nervous system involvement

Gurney, H. P. & Phadke, K., Jun 1987, In : Australian and New Zealand Journal of Medicine. 17, 3, p. 343-344 2 p.

Research output: Contribution to journalLetterResearchpeer-review

Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy

King, M. T., Hall, J., Caleo, S., Gurney, H. P. & Harnett, P. R., 2000, In : International Journal of Health Services. 30, 3, p. 557-579 23 p.

Research output: Contribution to journalArticleResearchpeer-review

Costs and Cost Analysis
Drug Therapy
Home Care Services
Nurses
Urban Hospitals

How to calculate the dose of chemotherapy

Gurney, H., 22 Apr 2002, In : British Journal of Cancer. 86, 8, p. 1297-1302 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Body Surface Area
Drug Therapy
Pharmaceutical Preparations
Guidelines
Testicular Neoplasms

Hypercalcaemia in small cell lung cancer: Report of a case associated with parathyroid hormone-related protein (PTHrP)

Stuart-Harris, R., Ahern, V., Danks, J. A., Gurney, H. & Martin, T. J., 1993, In : European Journal of Cancer. 29, 11, p. 1601-1604 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Parathyroid Hormone-Related Protein
Small Cell Lung Carcinoma
Hypercalcemia
Parathyroid Hormone Receptor Type 1
Neoplasms

I don't underdose my patients...do I? [3]

Gurney, H., Sep 2005, In : Lancet Oncology. 6, 9, p. 637-638 2 p.

Research output: Contribution to journalLetterResearchpeer-review

Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancer

Gurney, H., de Campos, E. S., Dodwell, D., Kamthan, A. & Thatcher, N., 1991, In : European Journal of Cancer and Clinical Oncology. 27, 5, p. 565-567 3 p.

Research output: Contribution to journalArticleResearchpeer-review

Ifosfamide
Mitomycin
Non-Small Cell Lung Carcinoma
Karnofsky Performance Status
Therapeutics

Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype

Gurney, H., Wong, M., Balleine, R. L., Rivory, L. P., McLachlan, A. J., Hoskins, J. M., Wilcken, N., Clarke, C. L., Mann, G. J., Collins, M., Delforce, S. E., Lynch, K. & Schran, H., 14 Jul 2007, In : Clinical Pharmacology and Therapeutics. 82, 1, p. 33-40 8 p.

Research output: Contribution to journalArticleResearchpeer-review

P-Glycoprotein
Genotype
Cytochrome P-450 CYP3A
Gastrointestinal Stromal Tumors
Homozygote

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia

Carus, A., Gurney, H., Gebski, V., Harnett, P., Hui, R., Kefford, R., Wilcken, N., Ladekarl, M., von der Maase, H. & Donskov, F., 2013, In : Journal of Translational Medicine. 11, p. 189 1 p.

Research output: Contribution to journalArticleResearchpeer-review

Chemotherapy
Neutropenia
Non-Small Cell Lung Carcinoma
Ovarian Neoplasms
Neutrophils

Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem?

Chang, D. K., Merrett, N. D., Biankin, A. V. & NSW Pancreatic Cancer Network, Jul 2008, In : Journal of Gastroenterology and Hepatology (Australia). 23, 7 Pt 1, p. 1036-45 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Pancreatic Neoplasms
Pancreatectomy
Mortality
Group Psychotherapy
Survival

Increased detections of leptomeningeal presentations in men with hormone refractory prostate cancer: An effect of improved systemic therapy?

Lin, C., Turner, S., Gurney, H. & Peduto, A., Aug 2008, In : Journal of Medical Imaging and Radiation Oncology. 52, 4, p. 376-381 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostatic Neoplasms
Hormones
Neoplasm Metastasis
Therapeutics
Natural History

Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor

Gurney, H., Anderson, H., Radford, J., Potter, M. R., Swindell, R., Steward, W., Kamthan, A., Chang, J., Weiner, J., Thatcher, N. & Crowther, D., 1992, In : European Journal of Cancer. 28, 1, p. 105-112 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Small Cell Lung Carcinoma
Granulocyte-Macrophage Colony-Stimulating Factor
Drug Therapy
Infection
Neutropenia
Inflammatory Breast Neoplasms
Epirubicin
Ifosfamide
Vincristine
Radiotherapy

Inhibitors of mTOR

Klümpen, H. J., Beijnen, J. H., Gurney, H. & Schellens, J. H. M., Dec 2010, In : Oncologist. 15, 12, p. 1262-1269 8 p.

Research output: Contribution to journalReview articleResearchpeer-review

Sirolimus
Pharmaceutical Preparations
Pharmacogenetics
Drug Interactions
Renal Cell Carcinoma

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer

Bishop, J. F., Dewar, J., Toner, G. C., Smith, J., Tattersall, M. H. N., Olver, I. N., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J., Stephenson, J. & Canetta, R., Aug 1999, In : Journal of Clinical Oncology. 17, 8, p. 2355-2364 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Paclitaxel
Combination Drug Therapy
Breast Neoplasms
Therapeutics
Infection

Inter- and intra-patient variability in pharmacokinetics of abiraterone acetate in metastatic prostate cancer

Arasaratnam, M., Crumbaker, M., Bhatnagar, A., McKay, M. J., Molloy, M. P. & Gurney, H., Jul 2019, In : Cancer Chemotherapy and Pharmacology. 84, 1, p. 139-146 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Pharmacokinetics
Prostatic Neoplasms
Pharmaceutical Preparations
Chemotherapy
Drug Therapy

Irinogenetics: How many stars are there in the sky?

Mathijssen, R. H. J. & Gurney, H., 1 Jun 2009, In : Journal of Clinical Oncology. 27, 16, p. 2578-2579 2 p.

Research output: Contribution to journalEditorialResearchpeer-review

Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure

Rowland, A., van Dyk, M., Mangoni, A. A., Miners, J. O., McKinnon, R. A., Wiese, M. D., Rowland, A., Kichenadasse, G., Gurney, H. & Sorich, M. J., 2017, In : Expert Opinion on Drug Metabolism and Toxicology. 13, 1, p. 31-49 19 p.

Research output: Contribution to journalReview articleResearchpeer-review

Pharmacokinetics
Phosphotransferases
Expert Testimony
Protein Kinase Inhibitors
Metabolism

Long-term follow-up of patients treated with intermittent hormone therapy for advanced prostate cancer

Hruby, G., Gurney, H., Turner, S., Berry, M., Harnett, P. & Gebski, V., May 1999, In : Prostate Journal. 1, 3, p. 138-143 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostatic Neoplasms
Hormones
Therapeutics
Goserelin
Androgen Antagonists

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Lawrence, N., Martin, A., Toner, G., Stockler, M., Buizen, L., Thomson, D., Gebski, V., Friedlander, M., Yeung, A., Wong, N., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S., Lewis, C., Vasey, P. & Grimison, P., 1 Dec 2016, In : Annals of oncology : official journal of the European Society for Medical Oncology. 27, 12, p. 2302-2303 2 p.

Research output: Contribution to journalLetterResearchpeer-review

Maintaining bone health in patients with prostate cancer

Holmes-Walker, J., Woo, H., Gurney, H., Do, V. T. & Chipps, D. R., 20 Feb 2006, In : Medical Journal of Australia. 184, 4, p. 176-179 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostatic Neoplasms
Bone and Bones
Androgens
Health
Bone Density

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: a Renal Cross Channel Group study

Colomba, E., Le Teuff, G., Eisen, T., Stewart, G. D., Fife, K., Larkin, J., Biondo, A., Pickering, L., Srinivasan, A., Boyle, H., Derosa, L., Sternberg, C. N., Recine, F., Ralph, C., Saldana, C., Barthélémy, P., Bernhard, J. C., Gurney, H., Verhoest, G., Vauleon, E. & 11 othersBigot, P., Berger, J., Pfister, C., Gravis, G., Rodier, J-M., Culine, S., Caty, A., Rolland, F., Priou, F., Escudier, B. & Albiges, L., 1 Jul 2017, In : European Journal of Cancer. 80, p. 55-62 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Sirolimus
Renal Cell Carcinoma
Treatment Failure
Kidney
Confidence Intervals

Metformin in prostate cancer: Two for the price of one

Clements, A., Gao, B., Yeap, S. H. O., Wong, M. K. Y., Ali, S. S. & Gurney, H., Dec 2011, In : Annals of Oncology. 22, 12, p. 2556-2560 5 p., mdr037.

Research output: Contribution to journalReview articleResearchpeer-review

Metformin
Prostatic Neoplasms
Androgens
Antineoplastic Agents
Clinical Trials

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

Mahon, K. L., Qu, W., Devaney, J., Paul, C., Castillo, L., Wykes, R. J., Chatfield, M. D., Boyer, M. J., Stockler, M. R., Marx, G., Gurney, H., Mallesara, G., Molloy, P. L., Horvath, L. G. & Clark, S. J., 28 Oct 2014, In : British Journal of Cancer. 111, 9, p. 1802-1809 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Glutathione Transferase
Genetic Markers
Epigenomics
Prostatic Neoplasms
Drug Therapy

MILGa-01-a first in human study assessing the safety and tolerability of chMIL-38 in prostate cancer

Sabanathan, D., Gurney, H., Gillatt, D., Trifunovic, M., Magnussen, J., Poursoltan, P., Shon, K. H. O., Walsh, B. J., Mazure, H., Velonas, V., Thurecht, K., Quach Truong, Wissmueller, S. & Campbell, D., Aug 2016, In : BJU international. 118, Suppl. 1, p. 14-15 2 p.

Research output: Contribution to journalMeeting abstractResearch